ISIN | LU0950668524 |
---|---|
Valor Number | 21964530 |
Bloomberg Global ID | |
Fund Name | UBS (Lux) Fund Solutions – UBS Core MSCI Europe UCITS ETF EUR acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). The sub-fund will take an exposure on the components of its Index. The proportionate exposure by the sub-fund to the component securities will be substantially achieved either through direct investment or through the use of derivatives or through a combination of both techniques. |
Peculiarities |
Current Price * | 10.12 EUR | 02.10.2025 |
---|---|---|
Previous Price * | 10.06 EUR | 01.10.2025 |
52 Week High * | 10.12 EUR | 02.10.2025 |
52 Week Low * | 9.58 EUR | 06.08.2025 |
NAV * | 10.12 EUR | 02.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 770,803,956 | |
Unit/Share Assets *** | 2,255,171 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
YTD Performance (in CHF) | - | - |
1 month | +4.69% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
3 months | +5.60% |
06.08.2025 - 02.10.2025
06.08.2025 02.10.2025 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 2.97% | |
---|---|---|
SAP SE | 2.17% | |
HSBC Holdings PLC | 1.90% | |
Novartis AG Registered Shares | 1.86% | |
Nestle SA | 1.84% | |
AstraZeneca PLC | 1.81% | |
Roche Holding AG | 1.78% | |
Shell PLC | 1.63% | |
Siemens AG | 1.58% | |
Novo Nordisk AS Class B | 1.35% | |
Last data update | 30.09.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.06% |
Ongoing Charges *** | 0.06% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |